arrow
C

Cristina Tassorelli

University of Pavia
H指数:67
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study

瑞美吉泮在多次急性偏头痛发作中的有效性:一项真实世界、前瞻性、多中心研究

2026-10-270
PRE
Migraine

偏头痛

2026-10-070
PRE
A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab – the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project

多学科多中心方法用于识别对erenumab反应的预测生物标志物——BIOMIGA项目第4阶段、欧洲、开放标签对照试验的方案

2026-09-210
OA
Migraine and Work-Disability: New Treatments Reduce Work-Related Burden Among Migraine Population

偏头痛与工作能力丧失:新疗法减轻偏头痛患者的工作相关负担

2026-09-040
OAAI
Clinical and instrumental phenotyping of gait in subjects with Cri du Chat syndrome

Cri du Chat综合征患者步态的临床与仪器表型分析

2026-08-250
OA
Clinical validation of a patient-friendly saliva microsampling approach to monitor perampanel levels in people with epilepsy

一种便捷唾液微取样方法在癫痫患者中监测佩雷莫潘水平的临床验证

2026-05-220
OA
Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH study

与托吡酯、阿米替林及其他具有疗效证据的选择性传统口服偏头痛预防药物相比,加卡纳zumab的有效性:TRIUMPH研究3个月结果

2026-04-010
OAAI
Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial

偏头痛患者中艾普尼珠单抗的持续疗效:针对先前预防性治疗失败且自报有精神科合并症的受试者的回顾性分析——安慰剂对照的DELIVER试验的后续分析

2026-02-110
OAAI
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)

拉米地坦在急性偏头痛治疗中的有效性与耐受性:一项真实世界、前瞻性、多中心研究(DART研究)

2025-12-210
OA
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial

在已接受2-4种先前预防性治疗失败的成人偏头痛患者中,接受依普利珠单抗治疗后头痛日频率的早期和持续性降低:一项随机DELIVER试验的事后分析

2025-12-150
OAAI
miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells

miR-382-5p和miR-34a在偏头痛中的作用:单核细胞中的表达及与外周血单个核细胞的表达事后探索性比较

2025-12-040
PRE
Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society

偏头痛的早期治疗——呼吁将预防重点从发作转向疾病进展:国际头痛学会立场声明

2025-10-240
OA
International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine

国际头痛协会关于非侵入性神经调控设备在偏头痛急性期和预防性治疗中应用的循证指南

2025-10-210
OA